• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤稿文章:跨膜蛋白88通过抑制转化生长因子-β1/信号转导和转录激活因子信号通路抑制肾近端小管上皮细胞纤维化。

Retracted Article: TMEM88 inhibits fibrosis in renal proximal tubular epithelial cells by suppressing the transforming growth factor-β1/Smad signaling pathway.

作者信息

Li Huicong, Wang Yunqian, Chen Baoping, Shi Jun

机构信息

Department of Nephrology, Huaihe Hospital of Henan University No. 115 Ximen Street Kaifeng 475000 Henan Province China

出版信息

RSC Adv. 2019 Feb 28;9(12):6928-6934. doi: 10.1039/c8ra10369k. eCollection 2019 Feb 22.

DOI:10.1039/c8ra10369k
PMID:35518485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9061109/
Abstract

Transmembrane protein 88 (TMEM88) belongs to a member of the TMEM family, and was reported to be involved in fibrogenesis. However, the biological role of TMEM88 in renal fibrosis has not been elucidated. Therefore, the objective of this study was to investigate the effect of TMEM88 on cell proliferation and extracellular matrix (ECM) accumulation in a TGF-β1-induced human renal proximal tubular epithelial cell line (HK2). Our results showed that TMEM88 was downregulated in renal fibrotic tissues and TGF-β1-treated HK2 cells. In addition, TMEM88 overexpression inhibited TGF-β1-induced cell proliferation and migration in HK2 cells. Furthermore, TMEM88 overexpression reduced the production of α-SMA, collagen I, and collagen III in TGF-β1-stimulated HK2 cells. Mechanistically, TMEM88 overexpression suppressed the phosphorylation status of Smad2 and Smad3 in TGF-β1-stimulated HK2 cells. In conclusion, data from our experiments demonstrate that TMEM88 plays a pivotal role in the pathological process of renal fibrosis. TMEM88 inhibited fibrosis in renal proximal tubular epithelial cells by suppressing the TGF-β1/Smad signaling pathway.

摘要

跨膜蛋白88(TMEM88)属于跨膜蛋白家族成员,据报道其参与了纤维化形成过程。然而,TMEM88在肾纤维化中的生物学作用尚未阐明。因此,本研究的目的是探讨TMEM88对转化生长因子-β1(TGF-β1)诱导的人肾近端小管上皮细胞系(HK2)细胞增殖和细胞外基质(ECM)积聚的影响。我们的结果显示,TMEM88在肾纤维化组织和TGF-β1处理的HK2细胞中表达下调。此外,TMEM88过表达抑制了TGF-β1诱导的HK2细胞增殖和迁移。而且,TMEM88过表达减少了TGF-β1刺激的HK2细胞中α-平滑肌肌动蛋白(α-SMA)、I型胶原和III型胶原的产生。机制上,TMEM过表达抑制了TGF-β1刺激的HK2细胞中Smad2和Smad3的磷酸化状态。总之,我们实验的数据表明TMEM88在肾纤维化的病理过程中起关键作用。TMEM88通过抑制TGF-β1/Smad信号通路抑制肾近端小管上皮细胞纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/dc67e209d597/c8ra10369k-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/e18dabe3e484/c8ra10369k-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/16f79dfbd3fb/c8ra10369k-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/e174cf76097f/c8ra10369k-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/dc67e209d597/c8ra10369k-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/e18dabe3e484/c8ra10369k-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/16f79dfbd3fb/c8ra10369k-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/e174cf76097f/c8ra10369k-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6df6/9061109/dc67e209d597/c8ra10369k-f4.jpg

相似文献

1
Retracted Article: TMEM88 inhibits fibrosis in renal proximal tubular epithelial cells by suppressing the transforming growth factor-β1/Smad signaling pathway.撤稿文章:跨膜蛋白88通过抑制转化生长因子-β1/信号转导和转录激活因子信号通路抑制肾近端小管上皮细胞纤维化。
RSC Adv. 2019 Feb 28;9(12):6928-6934. doi: 10.1039/c8ra10369k. eCollection 2019 Feb 22.
2
Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway.跨膜蛋白 88 通过调节 TGF-β1/Smad 通路抑制人胸膜间皮细胞转化生长因子-β1 诱导的细胞外基质积累和上皮-间充质转化程序。
J Recept Signal Transduct Res. 2022 Feb;42(1):60-66. doi: 10.1080/10799893.2020.1843493. Epub 2020 Nov 9.
3
TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.TMEM88 抑制瘢痕疙瘩成纤维细胞中细胞外基质的表达。
Biomed Pharmacother. 2017 Nov;95:1436-1440. doi: 10.1016/j.biopha.2017.09.047. Epub 2017 Sep 21.
4
MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1.微小RNA-140-5p通过直接靶向转化生长因子β受体1(TGFBR1),经由转化生长因子β1(TGF-β1)/Smad信号通路介导肾纤维化。
Front Physiol. 2020 Sep 4;11:1093. doi: 10.3389/fphys.2020.01093. eCollection 2020.
5
NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.NDRG2 敲低通过 TGF-β1/Smad3 通路促进肾小管上皮细胞纤维化。
Cell Tissue Res. 2017 Sep;369(3):603-610. doi: 10.1007/s00441-017-2643-7. Epub 2017 Jun 23.
6
MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.miRNA-708 通过直接靶向 TMEM88 调节肝星状细胞激活并增强细胞外基质积累。
J Cell Mol Med. 2020 Jul;24(13):7127-7140. doi: 10.1111/jcmm.15119. Epub 2020 May 28.
7
Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells.姜黄素通过 PPARγ 通路而非 Smad 通路抑制转化生长因子-β1 诱导的肾小管上皮细胞 EMT。
PLoS One. 2013;8(3):e58848. doi: 10.1371/journal.pone.0058848. Epub 2013 Mar 27.
8
Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-β1/TGF-β type I receptor/Smads signaling in proximal tubular epithelial cells.紫檀芪通过抑制近端肾小管上皮细胞中的 TGF-β1/TGF-β 型 I 受体/Smads 信号通路减轻果糖诱导的肾纤维化。
Eur J Pharmacol. 2019 Jan 5;842:70-78. doi: 10.1016/j.ejphar.2018.10.008. Epub 2018 Oct 16.
9
Src Homology 2 Domain-Containing Inositol 5'-Phosphatase Ameliorates High Glucose-Induced Extracellular Matrix Deposition via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Renal Tubular Epithelial Cells.含Src同源2结构域的肌醇5'-磷酸酶通过磷脂酰肌醇3-激酶/蛋白激酶B途径改善高糖诱导的肾小管上皮细胞外基质沉积。
J Cell Biochem. 2017 Aug;118(8):2271-2284. doi: 10.1002/jcb.25881. Epub 2017 Feb 28.
10
Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.大黄素通过抑制 TGF-β/Smad 信号通路改善肾间质纤维化。
Biochem Pharmacol. 2020 Oct;180:114079. doi: 10.1016/j.bcp.2020.114079. Epub 2020 Jun 6.

本文引用的文献

1
TMEM88 mediates inflammatory cytokines secretion by regulating JNK/P38 and canonical Wnt/β-catenin signaling pathway in LX-2 cells.TMEM88 通过调控 JNK/P38 和经典 Wnt/β-catenin 信号通路介导 LX-2 细胞炎症细胞因子的分泌。
Inflammopharmacology. 2018 Oct;26(5):1339-1348. doi: 10.1007/s10787-017-0419-z. Epub 2017 Nov 20.
2
TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.TMEM88 抑制瘢痕疙瘩成纤维细胞中细胞外基质的表达。
Biomed Pharmacother. 2017 Nov;95:1436-1440. doi: 10.1016/j.biopha.2017.09.047. Epub 2017 Sep 21.
3
Treatment of Renal Fibrosis-Turning Challenges into Opportunities.
肾纤维化的治疗——将挑战转化为机遇
Adv Chronic Kidney Dis. 2017 Mar;24(2):117-129. doi: 10.1053/j.ackd.2016.11.002.
4
New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.跨膜蛋白88(TMEM88)在癌症起始和进展中的新进展,特别强调Wnt信号通路。
J Cell Physiol. 2018 Jan;233(1):79-87. doi: 10.1002/jcp.25853. Epub 2017 Apr 27.
5
Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells.跨膜蛋白88通过促进活化肝星状细胞的凋亡和逆转来减轻肝纤维化。
Mol Immunol. 2016 Dec;80:58-67. doi: 10.1016/j.molimm.2016.11.002. Epub 2016 Nov 7.
6
Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.跨膜蛋白88(TMEM88)启动子低甲基化与卵巢癌铂耐药相关。
Gynecol Oncol. 2016 Sep;142(3):539-47. doi: 10.1016/j.ygyno.2016.06.017. Epub 2016 Jun 30.
7
TGF-β: the connecting link between nephropathy and fibrosis.转化生长因子-β:肾病与纤维化之间的联系环节
Immunopharmacol Immunotoxicol. 2016;38(1):39-49. doi: 10.3109/08923973.2015.1127382.
8
P311 promotes renal fibrosis via TGFβ1/Smad signaling.P311通过TGFβ1/Smad信号通路促进肾纤维化。
Sci Rep. 2015 Nov 30;5:17032. doi: 10.1038/srep17032.
9
Role of Smad signaling in kidney disease.Smad信号通路在肾脏疾病中的作用。
Int Urol Nephrol. 2015 Dec;47(12):1965-75. doi: 10.1007/s11255-015-1115-9. Epub 2015 Oct 3.
10
Cytosolic TMEM88 promotes triple-negative breast cancer by interacting with Dvl.胞质中的跨膜蛋白88(TMEM88)通过与Dvl相互作用促进三阴性乳腺癌。
Oncotarget. 2015 Sep 22;6(28):25034-45. doi: 10.18632/oncotarget.4379.